Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders

• Charles Dussiau,
• Henry Dupuy,
• Audrey Bidet,
• Mathieu Sauvezie,
• Anne-Charlotte De-Grande,
• Lisa Boureau,
• Etienne Riviere,
• Edouard Forcade,
• Fabrice Bonnet,
• Pierre-Yves Dumas,
• Pierre Duffau,
• Arnaud Pigneux,
• Jean-François Viallard,
• Sophie Dimicoli-Salazar,
• Estibaliz Lazaro

Affiliations

Charles Dussiau

1 Department of Hematology Biology, Molecular Hematology, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France

Henry Dupuy

2 Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France

Audrey Bidet

1 Department of Hematology Biology, Molecular Hematology, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France

Mathieu Sauvezie

3 Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France

Anne-Charlotte De-Grande

3 Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France

Lisa Boureau

1 Department of Hematology Biology, Molecular Hematology, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France

Etienne Riviere

2 Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France

Edouard Forcade

3 Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France

Fabrice Bonnet

4 Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Saint André Hospital, Bordeaux, France

Pierre-Yves Dumas

3 Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France

Pierre Duffau

5 Department of Internal Medicine and Clinical Immunology, Bordeaux University Hospital, Saint André Hospital, Bordeaux, France

Arnaud Pigneux

3 Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France

Jean-François Viallard

2 Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France

Sophie Dimicoli-Salazar

3 Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France

Estibaliz Lazaro

2 Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France